The Pharmaceutical Benefits Advisory Committee last month rejected the second application by Danish pharmaceutical giant Novo Nordisk to add Wegovy which is made from semaglutide to the Pharmaceutical Benefits Scheme as a treatment for severe obesity
Hypoglycemia (low blood sugar) occurs rarely in non-diabetic patients on semaglutide or tirzepatide alone but becomes a serious consideration if combined with insulin or sulfonylureas
10.1097/00001813-200109000-00010 Anticancer Drugs 67 TewK
The symptoms of hypoglycemia may be masked by alcohol intoxication, making detection and treatment more challenging
Four amino acids in CJC-1295 were replaced to enhance stability and half-life
Joo H, Choi JH, Burm E, Park H, Hong Y-C, Kim Y, Ha E-H, Kim Y, Kim B-N, Ha M (2018) Gender difference in the effects of lead exposure at different time windows on neurobehavioral development in 5-year-old children